Improves obesity, insulin resistance, NASH, liver injury, endotoxin‐TLR4‐NFκB inflammation, gut barrier dysfunction, and intestinal inflammation. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.